LipoScience (FRA:LI0) Other Long Term Assets : €0.47 Mil (As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is LipoScience Other Long Term Assets?

LipoScience's other long-term assets for the quarter that ended in Sep. 2014 was €0.47 Mil.

LipoScience's quarterly other long-term assets increased from Mar. 2014 (€0.43 Mil) to Jun. 2014 (€0.43 Mil) and increased from Jun. 2014 (€0.43 Mil) to Sep. 2014 (€0.47 Mil).

LipoScience's annual other long-term assets increased from Dec. 2011 (€2.72 Mil) to Dec. 2012 (€3.65 Mil) but then declined from Dec. 2012 (€3.65 Mil) to Dec. 2013 (€0.45 Mil).

LipoScience Other Long Term Assets Historical Data

The historical data trend for LipoScience's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LipoScience Other Long Term Assets Chart

LipoScience Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Other Long Term Assets

1.14

2.72

3.65

0.45

LipoScience Quarterly Data
	Mar11	Jun11	Dec11	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Other Long Term Assets	Get a 7-Day Free Trial								0.48	0.45	0.43	0.43	0.47

LipoScience Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

LipoScience (FRA:LI0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LipoScience Inc (FRA:LI0) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.liposcience.com

LipoScience Inc was incorporated under the laws of North Carolina in June 1994 under the name LipoMed, Inc. and reincorporated under the laws of Delaware in June 2000. The Company is a clinical diagnostic company into field of personalized diagnostics based on nuclear magnetic resonance technology. The Company's first diagnostic test, the NMR LipoProfile test, is cleared by the U.S. Food and Drug Administration, and directly measures the number of low density lipoprotein, particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. The Company's technology platform combines proprietary signal processing algorithms and NMR spectroscopic detection into a clinical analyzer to identify and quantify concentrations of lipoproteins and, potentially, small molecule metabolites. NMR detectors, or spectrometers, analyze a blood plasma or serum sample by subjecting it to a short pulse of radio frequency energy within a strong magnetic field. The Company currently markets NMR LipoProfile test through a direct sales force in 27 states. The Company competes against companies that offer other methods for measuring lipoproteins. Its competitors include Quest Diagnostics, Berkeley HeartLab, Inc., Atherotech, Inc. and SpectraCell Laboratories. The Company is subject to extensive and frequently changing federal, state and local laws and regulations governing various aspects of its business.

LipoScience (FRA:LI0) Headlines

No Headlines